{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:35:10Z","timestamp":1793723710456,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08398-x","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T09:02:35Z","timestamp":1727427755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Trial Of Pathogen-reduced Cryoprecipitate vs. Cryoprecipitated AHF to Lower Operative Transfusions (TOP-CLOT): study protocol for a single center, prospective, cluster randomized trial"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8042-1494","authenticated-orcid":false,"given":"Melissa M.","family":"Cushing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghann M.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Rand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Sinfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Keltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denden","family":"Benabdessadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Ivascu","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"DeSimone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"3","key":"8398_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jtcvs.2009.02.021","volume":"138","author":"MC Christensen","year":"2009","unstructured":"Christensen MC, Krapf S, Kempel A, von Heymann C. Costs of excessive postoperative hemorrhage in cardiac surgery. J Thorac Cardiovasc Surg. 2009;138(3):687\u201393. https:\/\/doi.org\/10.1016\/j.jtcvs.2009.02.021.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"22","key":"8398_CR2","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.698977","volume":"116","author":"GJ Murphy","year":"2007","unstructured":"Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22):2544\u201352. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.698977.","journal-title":"Circulation"},{"issue":"2","key":"8398_CR3","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/cc13798","volume":"18","author":"JS Hagemo","year":"2014","unstructured":"Hagemo JS, Stanworth S, Juffermans NP, et al. Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicentre observational study. Crit Care. 2014;18(2):R52. https:\/\/doi.org\/10.1186\/cc13798.","journal-title":"Crit Care"},{"issue":"6","key":"8398_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/EJA.0000000000000043","volume":"31","author":"D Faraoni","year":"2014","unstructured":"Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P. Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. Eur J Anaesthesiol. 2014;31(6):317\u201326. https:\/\/doi.org\/10.1097\/EJA.0000000000000043.","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"8398_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1213\/ANE.0b013e318292efa4","volume":"117","author":"K Karkouti","year":"2013","unstructured":"Karkouti K, Callum J, Crowther MA, et al. The relationship between fibrinogen levels after cardiopulmonary bypass and large volume red cell transfusion in cardiac surgery: an observational study. Anesth Anal. 2013;117(1):14. https:\/\/doi.org\/10.1213\/ANE.0b013e318292efa4.","journal-title":"Anesth Anal"},{"issue":"1","key":"8398_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13054-023-04327-7","volume":"27","author":"R Rossaint","year":"2023","unstructured":"Rossaint R, Afshari A, Bouillon B, et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care. 2023;27(1):80. https:\/\/doi.org\/10.1186\/s13054-023-04327-7.","journal-title":"Crit Care"},{"issue":"1","key":"8398_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.jvca.2017.06.026","volume":"32","author":"C Boer","year":"2018","unstructured":"Boer C, Meesters MI, Milojevic M, et al. 2017 EACTS\/EACTA guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth. 2018;32(1):88\u2013120. https:\/\/doi.org\/10.1053\/j.jvca.2017.06.026.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"8398_CR8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.athoracsur.2013.11.064","volume":"97","author":"K Wald\u00e9n","year":"2014","unstructured":"Wald\u00e9n K, Jeppsson A, Nasic S, Backlund E, Karlsson M. Low preoperative fibrinogen plasma concentration is associated with excessive bleeding after cardiac operations. Ann Thorac Surg. 2014;97(4):1199\u2013206. https:\/\/doi.org\/10.1016\/j.athoracsur.2013.11.064.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"8398_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.athoracsur.2016.01.005","volume":"102","author":"M Ranucci","year":"2016","unstructured":"Ranucci M, Pistuddi V, Baryshnikova E, Colella D, Bianchi P. Fibrinogen levels after cardiac surgical procedures: association with postoperative bleeding, trigger values, and target values. Ann Thorac Surg. 2016;102(1):78\u201385. https:\/\/doi.org\/10.1016\/j.athoracsur.2016.01.005.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"8398_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/vox.12279","volume":"109","author":"BL Pearse","year":"2015","unstructured":"Pearse BL, Smith I, Faulke D, et al. Protocol guided bleeding management improves cardiac surgery patient outcomes. Vox Sang. 2015;109(3):267\u201379. https:\/\/doi.org\/10.1111\/vox.12279. (Research Support, Non-U.S. Gov\u2019t).","journal-title":"Vox Sang"},{"key":"8398_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2023.02.054","author":"JV Hinton","year":"2023","unstructured":"Hinton JV, Xing Z, Fletcher CM, et al. Association of perioperative cryoprecipitate transfusion and mortality after cardiac surgery. Ann Thorac Surg. 2023. https:\/\/doi.org\/10.1016\/j.athoracsur.2023.02.054.","journal-title":"Ann Thorac Surg"},{"key":"8398_CR12","unstructured":"INTERCEPT Blood System for Cryoprecipitation [Package Insert]; For the manufacturing of pathogen reduced cryoprecipitated fibrinogen complex. Concord: Cerus Corporation; 2021."},{"issue":"23","key":"8398_CR13","doi-asserted-by":"publisher","first-page":"7496","DOI":"10.3390\/jcm12237496","volume":"12","author":"J-H Kim","year":"2023","unstructured":"Kim J-H, Kim K-S, Kwon H-M, et al. Comparison of fibrinogen concentrate and cryoprecipitate on major thromboembolic events after living donor liver transplantation. J Clin Med. 2023;12(23):7496. https:\/\/doi.org\/10.3390\/jcm12237496.","journal-title":"J Clin Med"},{"key":"8398_CR14","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1111\/trf.15614","volume":"60 Suppl 3","author":"MM Cushing","year":"2020","unstructured":"Cushing MM, Haas T, Karkouti K, Callum J. Which is the preferred blood product for fibrinogen replacement in the bleeding patient with acquired hypofibrinogenemia-cryoprecipitate or fibrinogen concentrate? Transfusion. 2020;60 Suppl 3:S17\u201323. https:\/\/doi.org\/10.1111\/trf.15614.","journal-title":"Transfusion"},{"issue":"3","key":"8398_CR15","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1213\/ANE.0000000000004384","volume":"130","author":"LA Downey","year":"2020","unstructured":"Downey LA, Andrews J, Hedlin H, et al. Fibrinogen concentrate as an alternative to cryoprecipitate in a postcardiopulmonary transfusion algorithm in infants undergoing cardiac surgery: a prospective randomized controlled trial. Anesthes Anal. 2020;130(3):740\u201351. https:\/\/doi.org\/10.1213\/ANE.0000000000004384.","journal-title":"Anesthes Anal"},{"issue":"20","key":"8398_CR16","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1001\/jama.2019.17312","volume":"322","author":"J Callum","year":"2019","unstructured":"Callum J, Farkouh ME, Scales DC, et al. Effect of fibrinogen concentrate vs cryoprecipitate on blood component transfusion after cardiac surgery: the FIBRES randomized clinical trial. JAMA. 2019;322(20):1966\u201376. https:\/\/doi.org\/10.1001\/jama.2019.17312.","journal-title":"JAMA"},{"issue":"2","key":"8398_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/jth.14665","volume":"18","author":"A Roy","year":"2020","unstructured":"Roy A, Stanford S, Nunn S, et al. Efficacy of fibrinogen concentrate in major abdominal surgery - a prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei. J Thromb Haemost. 2020;18(2):352\u201363. https:\/\/doi.org\/10.1111\/jth.14665.","journal-title":"J Thromb Haemost"},{"key":"8398_CR18","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. https:\/\/doi.org\/10.1136\/bmj.e7586.","journal-title":"BMJ"},{"issue":"5","key":"8398_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/vox.12517","volume":"112","author":"S Ramirez-Arcos","year":"2017","unstructured":"Ramirez-Arcos S, Jenkins C, Sheffield WP. Bacteria can proliferate in thawed cryoprecipitate stored at room temperature for longer than 4 h. Vox Sanguinis. 2017;112(5):477\u20139. https:\/\/doi.org\/10.1111\/vox.12517.","journal-title":"Vox Sanguinis"},{"issue":"5","key":"8398_CR20","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1111\/trf.16366","volume":"61","author":"C Thomson","year":"2021","unstructured":"Thomson C, Sobieraj-Teague M, Scott D, Duncan E, Abraham S, Roxby D. Extending the post-thaw viability of cryoprecipitate. Transfusion. 2021;61(5):1578\u201385. https:\/\/doi.org\/10.1111\/trf.16366.","journal-title":"Transfusion"},{"issue":"S2","key":"8398_CR21","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/trf.15180","volume":"59","author":"JL Fenderson","year":"2019","unstructured":"Fenderson JL, Meledeo MA, Rendo MJ, et al. Hemostatic characteristics of thawed, pooled cryoprecipitate stored for 35 days at refrigerated and room temperatures. Transfusion. 2019;59(S2):1560\u20137. https:\/\/doi.org\/10.1111\/trf.15180.","journal-title":"Transfusion"},{"issue":"5","key":"8398_CR22","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1111\/trf.15157","volume":"59","author":"MM Cushing","year":"2019","unstructured":"Cushing MM, Asmis LM, Harris RM, et al. Efficacy of a new pathogen-reduced cryoprecipitate stored 5 days after thawing to correct dilutional coagulopathy in vitro. Transfusion. 2019;59(5):1818\u201326. https:\/\/doi.org\/10.1111\/trf.15157.","journal-title":"Transfusion"},{"issue":"10","key":"8398_CR23","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1111\/trf.14259","volume":"57","author":"MM Cushing","year":"2017","unstructured":"Cushing MM, Fitzgerald MM, Harris RM, Asmis LM, Haas T. Influence of cryoprecipitate, factor XIII, and fibrinogen concentrate on hyperfibrinolysis. Transfusion. 2017;57(10):2502\u201310. https:\/\/doi.org\/10.1111\/trf.14259.","journal-title":"Transfusion"},{"issue":"3","key":"8398_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2450\/2012.0043-12","volume":"11","author":"C Solomon","year":"2013","unstructured":"Solomon C, Rahe-Meyer N, Sch\u00f6chl H, Ranucci M, G\u00f6rlinger K. Effect of haematocrit on fibrin-based clot firmness in the FIBTEM test. Blood Transfus. 2013;11(3):412\u20138. https:\/\/doi.org\/10.2450\/2012.0043-12.","journal-title":"Blood Transfus"},{"key":"8398_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2015.11.013","volume":"74","author":"SJ Arnup","year":"2016","unstructured":"Arnup SJ, Forbes AB, Kahan BC, Morgan KE, McKenzie JE. Appropriate statistical methods were infrequently used in cluster-randomized crossover trials. J Clin Epidemiol. 2016;74:40\u201350. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.11.013.","journal-title":"J Clin Epidemiol"},{"issue":"5\u20136","key":"8398_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/sim.4780120513","volume":"12","author":"GW Williams","year":"1993","unstructured":"Williams GW, Davis RL, Getson AJ, et al. Monitoring of clinical trials and interim analyses from a drug sponsor\u2019s point of view. Stat Med. 1993;12(5\u20136):481\u201392. https:\/\/doi.org\/10.1002\/sim.4780120513.","journal-title":"Stat Med"},{"issue":"4","key":"8398_CR27","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","volume":"41","author":"SAM Nashef","year":"2012","unstructured":"Nashef SAM, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734\u201344. https:\/\/doi.org\/10.1093\/ejcts\/ezs043. discussion 744-745.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"11","key":"8398_CR28","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1111\/trf.15437","volume":"59","author":"MM Cushing","year":"2019","unstructured":"Cushing MM, Haas T. Fibrinogen concentrate for perioperative bleeding: what can we learn from the clinical trials? Transfusion. 2019;59(11):3295\u20137. https:\/\/doi.org\/10.1111\/trf.15437.","journal-title":"Transfusion"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08398-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08398-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08398-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T09:08:17Z","timestamp":1727428097000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08398-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8398"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08398-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol has been reviewed and approved by the IRB of Weill Cornell Medicine through a collaboration with the BRANY IRB (Lake Success, NY). The need for consent was waived by the IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MMC is a consultant for Cerus Corporation, Octapharma, Haemonetics, and CSL Behring. NK is a full-time employee of Cerus Corporation and owns stock in the company. TH is a consultant for Cerus Corporation, Octapharma, Grifols, and CSL Behring. Remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"625"}}